MRS4719-d3
MRS4719-d3 is the deuterium labeled MRS4719. MRS4719 is a potent P2X4 receptor antagonist with an IC50 value of 0.503 μM for human P2X4 receptor. MRS4719 can reduce infarct volume and reduce brain atrophy, showing neuroprotective and neuro-rehabilitative activities in ischemic stroke model. MRS4719 also reduces ATP-induced [Ca2+]i influx in primary human monocyte-derived macrophages. MRS4719 can be used to research ischemic stroke[1].
Product Specifications
UNSPSC
12352005
Target
Isotope-Labeled Compounds; P2X Receptor
Related Pathways
Membrane Transporter/Ion Channel; Others
Field of Research
Neurological Disease
Smiles
CC[NH+](CC)CC.O=C(NC1=C2C=CC=CC2=CC=C1N3C4=C([2H])C(C([N-]5)=NOC5=S)=NC([2H])=C4[2H])CC3=O
Molecular Formula
C26H25D3N6O3S
Molecular Weight
507.62
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral mouse Prl2a1 shRNA (UAS) - Lentiviral mouse Prl2a1 shRNA (UAS) (25)
RNF62/MKRN2 Polyclonal Antibody, APC Conjugated
